{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:46:00Z","timestamp":1789519560573,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.ppat.1012808","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000}}],"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>Although structures of pre- and post-fusion conformations of SARS-CoV-2 spikes have been solved by cryo-electron microscopy, the transient spike conformations that mediate virus fusion with host cell membranes remain poorly understood. In this study, we used a peptide fusion inhibitor corresponding to the heptad repeat 2 (HR2) in the S2 transmembrane subunit of the spike to investigate fusion-intermediate conformations that involve exposure of the highly conserved heptad repeat 1 (HR1). The HR2 peptide disrupts the assembly of the HR1 and HR2 regions of the spike, which form a six-helix bundle during the transition to the post-fusion conformation. We show that binding of the spike S1 subunit to ACE2 is sufficient to induce conformational changes that allow S1 shedding and enable the HR2 peptide to bind to fusion-intermediate conformations of S2 and inhibit membrane fusion. When TMPRSS2 is also present, the peptide captures an S2\u2019 fusion intermediate though the proportion of the S2\u2019 intermediate relative to the S2 intermediate is lower in Omicron variants than pre-Omicron variants. In spikes lacking the natural S1\/S2 furin cleavage site, ACE2 binding alone is not sufficient for trapping fusion intermediates, but the presence of ACE2 and TMPRSS2 allows peptide trapping of an S2\u2019 intermediate. These results indicate that, in addition to ACE2 engagement, at least one spike cleavage is needed for unwinding S2 into an HR2 peptide-sensitive, fusion-intermediate conformation. Our findings elucidate fusion-intermediate conformations of SARS-CoV-2 spike variants that expose conserved sites on spike that could be targeted by inhibitors or antibodies.<\/jats:p>","DOI":"10.1371\/journal.ppat.1012808","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:20:19Z","timestamp":1744122019000},"page":"e1012808","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1\/S2 or S2\u2019 site"],"prefix":"10.1371","volume":"21","author":[{"given":"Sabrina","family":"Lusvarghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseebullah","family":"Baha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabari Nath","family":"Neerukonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-1289","authenticated-orcid":true,"given":"Carol D.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"1","key":"ppat.1012808.ref001","doi-asserted-by":"crossref","first-page":"msab327","DOI":"10.1093\/molbev\/msab327","article-title":"The Emergence of the Spike Furin Cleavage Site in SARS-CoV-2","volume":"39","author":"YA Chan","year":"2022","journal-title":"Mol Biol Evol"},{"issue":"1","key":"ppat.1012808.ref002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"CB Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"ppat.1012808.ref003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.virol.2011.02.020","article-title":"Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion","volume":"413","author":"G Simmons","year":"2011","journal-title":"Virology"},{"issue":"9","key":"ppat.1012808.ref004","doi-asserted-by":"crossref","first-page":"e00002-21","DOI":"10.1128\/JVI.00002-21","article-title":"SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation","volume":"95","author":"BF H\u00f6rnich","year":"2021","journal-title":"J Virol"},{"issue":"5","key":"ppat.1012808.ref005","doi-asserted-by":"crossref","first-page":"e02304-20","DOI":"10.1128\/JVI.02304-20","article-title":"Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects","volume":"95","author":"HT Nguyen","year":"2021","journal-title":"J Virol"},{"issue":"7969","key":"ppat.1012808.ref006","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41586-023-06273-4","article-title":"Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane","volume":"619","author":"W Shi","year":"2023","journal-title":"Nature"},{"issue":"18","key":"ppat.1012808.ref007","doi-asserted-by":"crossref","first-page":"e2213332120","DOI":"10.1073\/pnas.2213332120","article-title":"In situ architecture and membrane fusion of SARS-CoV-2 Delta variant","volume":"120","author":"Y Song","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6710","key":"ppat.1012808.ref008","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1126\/science.adn5658","article-title":"Structure and inhibition of SARS-CoV-2 spike refolding in membranes","volume":"385","author":"MW Grunst","year":"2024","journal-title":"Science"},{"issue":"38","key":"ppat.1012808.ref009","doi-asserted-by":"crossref","first-page":"e2209514119","DOI":"10.1073\/pnas.2209514119","article-title":"SARS-CoV-2 requires acidic pH to infect cells","volume":"119","author":"AJB Kreutzberger","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6510","key":"ppat.1012808.ref010","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"C-L Hsieh","year":"2020","journal-title":"Science"},{"issue":"10","key":"ppat.1012808.ref011","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41594-020-0483-8","article-title":"Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation","volume":"27","author":"M McCallum","year":"2020","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"ppat.1012808.ref012","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41467-023-37786-1","article-title":"High-throughput identification of prefusion-stabilizing mutations in SARS-CoV-2 spike","volume":"14","author":"TJC Tan","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"ppat.1012808.ref013","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the closed SARS-CoV-2 spike trimer","volume":"12","author":"J Juraszek","year":"2021","journal-title":"Nat Commun"},{"issue":"6511","key":"ppat.1012808.ref014","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Y Cai","year":"2020","journal-title":"Science"},{"issue":"2","key":"ppat.1012808.ref015","doi-asserted-by":"crossref","first-page":"108630","DOI":"10.1016\/j.celrep.2020.108630","article-title":"D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1\/S2 Junction","volume":"34","author":"SM-C Gobeil","year":"2021","journal-title":"Cell Rep"},{"issue":"11","key":"ppat.1012808.ref016","first-page":"2050-2068.e6","article-title":"Structural diversity of the SARS-CoV-2 Omicron spike","volume":"82","author":"SM-C Gobeil","year":"2022","journal-title":"Mol Cell"},{"issue":"6541","key":"ppat.1012808.ref017","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.abf2303","article-title":"Structural impact on SARS-CoV-2 spike protein by D614G substitution","volume":"372","author":"J Zhang","year":"2021","journal-title":"Science"},{"issue":"7837","key":"ppat.1012808.ref018","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","article-title":"Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion","volume":"588","author":"DJ Benton","year":"2020","journal-title":"Nature"},{"issue":"6","key":"ppat.1012808.ref019","doi-asserted-by":"crossref","first-page":"867-879.e5","DOI":"10.1016\/j.chom.2020.11.004","article-title":"Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains","volume":"28","author":"T Zhou","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"6583","key":"ppat.1012808.ref020","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.abn8652","article-title":"Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement","volume":"375","author":"M McCallum","year":"2022","journal-title":"Science"},{"issue":"1","key":"ppat.1012808.ref021","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Z Zhao","year":"2022","journal-title":"Nat Commun"},{"issue":"6483","key":"ppat.1012808.ref022","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"D Wrapp","year":"2020","journal-title":"Science"},{"issue":"6607","key":"ppat.1012808.ref023","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abq2679","article-title":"ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies","volume":"377","author":"JS Low","year":"2022","journal-title":"Science"},{"issue":"6","key":"ppat.1012808.ref024","doi-asserted-by":"crossref","first-page":"1276-1289.e6","DOI":"10.1016\/j.immuni.2021.03.023","article-title":"Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant","volume":"54","author":"C Graham","year":"2021","journal-title":"Immunity"},{"issue":"5","key":"ppat.1012808.ref025","doi-asserted-by":"crossref","first-page":"1297-1314.e24","DOI":"10.1016\/j.cell.2025.01.012","article-title":"Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target","volume":"188","author":"L Xing","year":"2025","journal-title":"Cell"},{"issue":"4","key":"ppat.1012808.ref026","doi-asserted-by":"crossref","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"S Xia","year":"2019","journal-title":"Sci Adv"},{"issue":"21","key":"ppat.1012808.ref027","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1073\/pnas.89.21.10537","article-title":"A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition","volume":"89","author":"C Wild","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1012808.ref028","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01697-07","article-title":"Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway","volume":"82","author":"M Ujike","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"ppat.1012808.ref029","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nsb0498-276","article-title":"Capture of an early fusion-active conformation of HIV-1 gp41","volume":"5","author":"RA Furuta","year":"1998","journal-title":"Nat Struct Biol"},{"key":"ppat.1012808.ref030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","article-title":"Mechanisms of viral membrane fusion and its inhibition","volume":"70","author":"DM Eckert","year":"2001","journal-title":"Annu Rev Biochem"},{"issue":"11","key":"ppat.1012808.ref031","doi-asserted-by":"crossref","first-page":"e0120324","DOI":"10.1128\/mbio.01203-24","article-title":"Biochemical analysis of packing and assembling heptad repeat motifs in the coronavirus spike protein trimer","volume":"15","author":"J Kobayashi","year":"2024","journal-title":"mBio"},{"issue":"7","key":"ppat.1012808.ref032","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41423-020-0374-2","article-title":"Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein","volume":"17","author":"S Xia","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"6536","key":"ppat.1012808.ref033","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.abf4896","article-title":"Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets","volume":"371","author":"RD de Vries","year":"2021","journal-title":"Science"},{"issue":"4","key":"ppat.1012808.ref034","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"S Xia","year":"2020","journal-title":"Cell Res"},{"issue":"23","key":"ppat.1012808.ref035","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1021\/acs.jmedchem.1c01681","article-title":"Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor","volume":"64","author":"M Zheng","year":"2021","journal-title":"J Med Chem"},{"key":"ppat.1012808.ref036","doi-asserted-by":"crossref","first-page":"105571","DOI":"10.1016\/j.antiviral.2023.105571","article-title":"Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides","volume":"212","author":"Y Hu","year":"2023","journal-title":"Antiviral Res"},{"issue":"14","key":"ppat.1012808.ref037","doi-asserted-by":"crossref","first-page":"e00635-20","DOI":"10.1128\/JVI.00635-20","article-title":"Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity","volume":"94","author":"Y Zhu","year":"2020","journal-title":"J Virol"},{"issue":"40","key":"ppat.1012808.ref038","doi-asserted-by":"crossref","first-page":"e2210990119","DOI":"10.1073\/pnas.2210990119","article-title":"Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein","volume":"119","author":"K Yang","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"ppat.1012808.ref039","doi-asserted-by":"crossref","first-page":"eabo3153","DOI":"10.1126\/sciadv.abo3153","article-title":"Intermediates in SARS-CoV-2 spike-mediated cell entry","volume":"8","author":"TC Marcink","year":"2022","journal-title":"Sci Adv"},{"issue":"16","key":"ppat.1012808.ref040","doi-asserted-by":"crossref","first-page":"e107821","DOI":"10.15252\/embj.2021107821","article-title":"TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells","volume":"40","author":"J Koch","year":"2021","journal-title":"EMBO J"},{"issue":"3","key":"ppat.1012808.ref041","doi-asserted-by":"crossref","first-page":"e0248348","DOI":"10.1371\/journal.pone.0248348","article-title":"Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2","volume":"16","author":"SN Neerukonda","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1012808.ref042","doi-asserted-by":"crossref","first-page":"e2111400119","DOI":"10.1073\/pnas.2111400119","article-title":"SARS-CoV-2 spreads through cell-to-cell transmission","volume":"119","author":"C Zeng","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ppat.1012808.ref043","doi-asserted-by":"crossref","first-page":"e1009246","DOI":"10.1371\/journal.ppat.1009246","article-title":"Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion","volume":"17","author":"G Papa","year":"2021","journal-title":"PLoS Pathog"},{"issue":"8","key":"ppat.1012808.ref044","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"BJ Willett","year":"2022","journal-title":"Nat Microbiol"},{"issue":"23","key":"ppat.1012808.ref045","doi-asserted-by":"crossref","first-page":"e106267","DOI":"10.15252\/embj.2020106267","article-title":"Syncytia formation by SARS-CoV-2-infected cells","volume":"39","author":"J Buchrieser","year":"2020","journal-title":"EMBO J"},{"issue":"8","key":"ppat.1012808.ref046","doi-asserted-by":"crossref","first-page":"2212-2228.e12","DOI":"10.1016\/j.cell.2021.02.053","article-title":"Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system","volume":"184","author":"ML Yeung","year":"2021","journal-title":"Cell"},{"issue":"3","key":"ppat.1012808.ref047","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JVI.77.3.1666-1671.2003","article-title":"Peptides trap the human immunodeficiency virus type 1 envelope glycoprotein fusion intermediate at two sites","volume":"77","author":"Y He","year":"2003","journal-title":"J Virol"},{"key":"ppat.1012808.ref048","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12977-014-0086-8","article-title":"Resistance to N-peptide fusion inhibitors correlates with thermodynamic stability of the gp41 six-helix bundle but not HIV entry kinetics","volume":"11","author":"CJ De Feo","year":"2014","journal-title":"Retrovirology"},{"issue":"13","key":"ppat.1012808.ref049","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1128\/JVI.76.13.6780-6790.2002","article-title":"Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates","volume":"76","author":"H Golding","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"ppat.1012808.ref050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbrc.2007.05.092","article-title":"Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity","volume":"359","author":"L Du","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"ppat.1012808.ref051","doi-asserted-by":"crossref","first-page":"e0047422","DOI":"10.1128\/jvi.00474-22","article-title":"SARS-CoV-2 Spike Furin Cleavage Site and S2\u2019 Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner","volume":"96","author":"M Lavie","year":"2022","journal-title":"J Virol"},{"key":"ppat.1012808.ref052","doi-asserted-by":"crossref","first-page":"147144","DOI":"10.1016\/j.gene.2022.147144","article-title":"Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection","volume":"856","author":"Z Wang","year":"2023","journal-title":"Gene"},{"issue":"1","key":"ppat.1012808.ref053","doi-asserted-by":"crossref","first-page":"e2111199119","DOI":"10.1073\/pnas.2111199119","article-title":"SARS-CoV-2 spike engagement of ACE2 primes S2\u2019 site cleavage and fusion initiation","volume":"119","author":"S Yu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"ppat.1012808.ref054","doi-asserted-by":"crossref","first-page":"e0012822","DOI":"10.1128\/jvi.00128-22","article-title":"Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity","volume":"96","author":"R Essalmani","year":"2022","journal-title":"J Virol"},{"issue":"19","key":"ppat.1012808.ref055","doi-asserted-by":"crossref","first-page":"e0130122","DOI":"10.1128\/jvi.01301-22","article-title":"The Spike-Stabilizing D614G Mutation Interacts with S1\/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants","volume":"96","author":"S Gellenoncourt","year":"2022","journal-title":"J Virol"},{"issue":"7819","key":"ppat.1012808.ref056","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","article-title":"A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2","volume":"584","author":"R Shi","year":"2020","journal-title":"Nature"},{"issue":"7839","key":"ppat.1012808.ref057","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"CO Barnes","year":"2020","journal-title":"Nature"},{"issue":"7","key":"ppat.1012808.ref058","doi-asserted-by":"crossref","first-page":"110812","DOI":"10.1016\/j.celrep.2022.110812","article-title":"LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants","volume":"39","author":"K Westendorf","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"ppat.1012808.ref059","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41392-022-00903-5","article-title":"Omicron adopts a different strategy from Delta and other variants to adapt to host","volume":"7","author":"X Du","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"7902","key":"ppat.1012808.ref060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"B Meng","year":"2022","journal-title":"Nature"},{"issue":"3","key":"ppat.1012808.ref061","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41594-022-00735-5","article-title":"The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes","volume":"29","author":"SM Costello","year":"2022","journal-title":"Nat Struct Mol Biol"},{"key":"ppat.1012808.ref062","doi-asserted-by":"crossref","first-page":"e63646","DOI":"10.7554\/eLife.63646","article-title":"SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets","volume":"10","author":"PV Raghuvamsi","year":"2021","journal-title":"Elife"},{"issue":"12","key":"ppat.1012808.ref063","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41422-022-00746-3","article-title":"A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein","volume":"32","author":"W Pang","year":"2022","journal-title":"Cell Res"},{"issue":"10","key":"ppat.1012808.ref064","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1021\/acscentsci.0c01056","article-title":"Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein","volume":"6","author":"L Casalino","year":"2020","journal-title":"ACS Cent Sci"},{"issue":"7","key":"ppat.1012808.ref065","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.3390\/v15071500","article-title":"SARS-CoV-2 Spike Protein Is Capable of Inducing Cell-Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies","volume":"15","author":"N Reuter","year":"2023","journal-title":"Viruses"},{"issue":"14","key":"ppat.1012808.ref066","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1128\/JVI.74.14.6614-6621.2000","article-title":"Functional implications of the human T-lymphotropic virus type 1 transmembrane glycoprotein helical hairpin structure","volume":"74","author":"AL Maerz","year":"2000","journal-title":"J Virol"},{"issue":"12","key":"ppat.1012808.ref067","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1096\/fj.13-232371","article-title":"Structural characterization of a fusion glycoprotein from a retrovirus that undergoes a hybrid 2-step entry mechanism","volume":"27","author":"H Aydin","year":"2013","journal-title":"FASEB J"},{"issue":"11","key":"ppat.1012808.ref068","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/S2213-2600(20)30418-5","article-title":"Human recombinant soluble ACE2 in severe COVID-19","volume":"8","author":"A Zoufaly","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"33","key":"ppat.1012808.ref069","doi-asserted-by":"crossref","first-page":"e2208011119","DOI":"10.1073\/pnas.2208011119","article-title":"Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH","volume":"119","author":"E Garcia-Moro","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"ppat.1012808.ref070","doi-asserted-by":"crossref","first-page":"12132","DOI":"10.1128\/JVI.79.19.12132-12147.2005","article-title":"Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1","volume":"79","author":"X Yang","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"ppat.1012808.ref071","doi-asserted-by":"crossref","first-page":"e1004595","DOI":"10.1371\/journal.ppat.1004595","article-title":"Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry","volume":"11","author":"OF Brandenberg","year":"2015","journal-title":"PLoS Pathog"},{"issue":"5","key":"ppat.1012808.ref072","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/v12050513","article-title":"Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays","volume":"12","author":"KHD Crawford","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"ppat.1012808.ref073","first-page":"701-712.e9","article-title":"Gain of Additional BIRC3 Protein Functions through 3\u2019-UTR-Mediated Protein Complex Formation","volume":"74","author":"S-H Lee","year":"2019","journal-title":"Mol Cell"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1012808","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T14:10:37Z","timestamp":1745244637000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1012808"}},"subtitle":[],"editor":[{"given":"Nuria","family":"Verdaguer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1012808","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.12.05.627124","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]}}}